Contact ChineseDrama.info

Name

Email *

Message *

Monday, 11 October 2021

Mo Ran


Mo Ran China Web Drama
Web Drama: Mo Ran
Chinese Title: 莫染 / Mo Ran
Broadcast Website: Youku
Broadcast Date: TBA
Genre: Historical, Romance, Time Travel
Language: Mandarin
Episodes: 36
Director: Wang Xiaoming, Wang Xiaokang
Screenwriter: Liu Yue, Feng Ranbai
Production Company: Dreamax
Chief Producer: Xie Ying
Producer: Liu Chang, Zhang Xiaozhou
Origin: China
Source: Adapted from the novel Ming Men Yi Nv (名门医女) by Xi Xing

Love Meter


Synopsis and Plot Summary

Modern-day doctor Qi Yue accidentally travels to the "Great Qing" while trying to save someone. She relies on her superb skills to break the shackles of the olden times to find the true meaning behind the practice of medicine.

By chance, female surgeon Qi Yue (Xia Meng) finds herself in the ancient times inside the body of Qi Yueniang, the young master's wife who has been murdered. Qi Yue's arrival causes a commotion. In this new environment, she has no choice but to thrive amidst the dangers as she tries to find a way back home.

When her husband Chang Yuncheng (Fu Xinbo) returns from guarding the borders under imperial orders, Qi Yue's already difficult situation is further tested. The two who are only married in name have to live under the same roof. Feelings of mutual distrust eventually turn into feelings of love. Qi Yue also manages to rely on her medical skills to defuse every danger. Upon seeing the unique benefits of traditional Chinese medicine, she begins studying under the guidance of masters and becomes a doctor of her generation.



Fun Facts

  • Filming wrapped on December 26, 2021.


Cast
Mo Ran Fu Xinbo Fu Xinbo as Chang Yuncheng
Mo Ran Xia Meng Xia Meng as Qi Yue

Supporting Cast
Stills
Mo Ran China Web Drama
Show more...

Posters
Mo Ran China Web Drama
Show more...

Behind The Scenes
Mo Ran China Web Drama
Show more...


Let us know why you like Mo Ran in the comments section. Please also share these fun facts using the social media buttons below.




No comments:

Post a Comment